CDTX vs DVA · rev $1.3M vs P/E 14, rev $12.82B
Cidara Therapeutics Inc (CDTX) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
CDTX currently screens at market cap $6.96B. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the CDTX and DVA stock pages for the full models.
Not investment advice.